Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,864,000 | 652,000 | 965,000 | 1,520,000 | 1,610,000 |
| Marketable Securities | 16,814,000 | 16,831,000 | 12,987,000 | 10,432,000 | 12,807,000 |
| Receivables | 9,216,000 | 9,342,000 | 10,415,000 | 8,636,000 | 8,626,000 |
| Inventories | 6,295,000 | 5,863,000 | 5,942,000 | 5,699,000 | 6,701,000 |
| Other current assets | 910,000 | 838,000 | 2,028,000 | 1,632,000 | 340,000 |
| TOTAL | $39,057,000 | $36,685,000 | $35,389,000 | $30,677,000 | $33,067,000 |
| Non-Current Assets | |||||
| PPE Net | 17,477,000 | 17,299,000 | 17,703,000 | 18,156,000 | 17,961,000 |
| Investments And Advances | 4,216,000 | 4,420,000 | 5,430,000 | 6,142,000 | 5,962,000 |
| Intangibles | 56,676,000 | 57,289,000 | 59,454,000 | 57,856,000 | 57,151,000 |
| Other Non-Current Assets | 4,803,000 | 4,268,000 | 4,313,000 | 3,944,000 | 5,917,000 |
| TOTAL | $83,172,000 | $83,276,000 | $86,900,000 | $86,098,000 | $86,991,000 |
| Total Assets | $122,229,000 | $119,961,000 | $122,289,000 | $116,775,000 | $120,058,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,858,000 | 12,204,000 | 10,692,000 | 8,818,000 | 9,396,000 |
| Accounts payable and accrued liabilities | 2,329,000 | 2,480,000 | 2,479,000 | 2,587,000 | 1,998,000 |
| Accrued Expenses | 1,835,000 | 1,599,000 | 1,636,000 | 1,740,000 | 1,539,000 |
| Other current liabilities | 6,249,000 | 5,785,000 | 6,857,000 | 5,850,000 | 5,049,000 |
| TOTAL | $25,239,000 | $25,158,000 | $24,637,000 | $23,909,000 | $21,660,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,956,000 | 6,765,000 | 7,144,000 | 5,755,000 | 6,439,000 |
| Other Non-Current Liabilities | 8,689,000 | 8,566,000 | 8,407,000 | 8,722,000 | 8,548,000 |
| TOTAL | $28,607,000 | $28,098,000 | $28,604,000 | $27,489,000 | $29,867,000 |
| Total Liabilities | $53,846,000 | $53,256,000 | $53,241,000 | $51,398,000 | $51,527,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,530,995 | 7,550,776 | 7,630,537 | 7,625,056 | 7,631,523 |
| Common Shares | 437,000 | 437,000 | 436,000 | 435,000 | 434,000 |
| Retained earnings | 35,347,000 | 32,003,000 | 31,707,000 | 29,382,000 | 31,191,000 |
| Other shareholders' equity | -339,000 | -1,181,000 | 408,000 | -1,484,000 | -2,831,000 |
| TOTAL | $68,383,000 | $66,705,000 | $69,048,000 | $65,377,000 | $68,531,000 |
| Total Liabilities And Equity | $122,229,000 | $119,961,000 | $122,289,000 | $116,775,000 | $120,058,000 |